Imago Biosciences Inc (IMGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,593 | 8,984 | 19,266 | 0 | 0 |
| Marketable Securities | 74,516 | 73,756 | 57,375 | 0 | 0 |
| TOTAL | $82,635 | $84,660 | $77,822 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 4 | 5 | 8 | N/A | N/A |
| Investments And Advances | 0 | 6,501 | 19,689 | 0 | 0 |
| Other Non-Current Assets | 2,549 | 2,212 | 1,414 | 0 | 0 |
| TOTAL | $2,553 | $8,718 | $21,111 | $N/A | $N/A |
| Total Assets | $85,188 | $93,378 | $98,933 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,964 | 2,768 | 1,379 | 0 | 0 |
| Accrued Expenses | 4,431 | 3,560 | 3,726 | 0 | 0 |
| TOTAL | $6,395 | $6,328 | $5,105 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 162,612 | 162,612 | 162,612 | 0 | 0 |
| TOTAL | $162,612 | $162,612 | $162,612 | $N/A | $N/A |
| Total Liabilities | $169,007 | $168,940 | $167,717 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,433 | 32,116 | N/A | N/A | N/A |
| Retained earnings | -86,257 | -77,451 | -70,342 | 0 | 0 |
| Other shareholders' equity | 17 | 9 | -3 | 0 | 0 |
| TOTAL | $-83,819 | $-75,562 | $-68,784 | $0 | $0 |
| Total Liabilities And Equity | $85,188 | $93,378 | $98,933 | $0 | $0 |